These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Preliminary application of micro-SPECT/CT imaging by Zhang Y; Meng L; Li B; Tan H; Lin QY; Cheng D; Shi H Chem Biol Drug Des; 2019 Apr; 93(4):447-453. PubMed ID: 30381892 [TBL] [Abstract][Full Text] [Related]
10. Noninvasive PET Imaging of CDK4/6 Activation in Breast Cancer. Ramos N; Baquero-Buitrago J; Ben Youss Gironda Z; Wadghiri YZ; Reiner T; Boada FE; Carlucci G J Nucl Med; 2020 Mar; 61(3):437-442. PubMed ID: 31481582 [TBL] [Abstract][Full Text] [Related]
11. Rational Design and Comparison of Novel Meng L; Fang J; Zhang J; Li H; Xia D; Zhuang R; Chen H; Huang J; Li Y; Zhang X; Guo Z J Med Chem; 2024 May; 67(10):8460-8472. PubMed ID: 38717104 [TBL] [Abstract][Full Text] [Related]
12. Coligand effects on the solution stability, biodistribution and metabolism of the (99m)Tc-labeled cyclic RGDfK tetramer. Liu S; Kim YS; Hsieh WY; Gupta Sreerama S Nucl Med Biol; 2008 Jan; 35(1):111-21. PubMed ID: 18158950 [TBL] [Abstract][Full Text] [Related]
13. Formulation and Preclinical Testing of Tc-99m-Labeled HYNIC-Glc-FAPT as a FAP-Targeting Tumor Radiotracer. Yang X; Li G; Ruan C; Hu K; Tang G Bioconjug Chem; 2023 Nov; 34(11):2133-2143. PubMed ID: 37874952 [TBL] [Abstract][Full Text] [Related]
14. Gallium-68 Labeling of the Cyclin-Dependent Kinase 4/6 Inhibitors as Positron Emission Tomography Radiotracers for Tumor Imaging. Liu C; Yang Z; Liu M; Wang X; Song S; Xu X; Yang Z ACS Omega; 2021 Nov; 6(47):32253-32261. PubMed ID: 34870045 [TBL] [Abstract][Full Text] [Related]
15. Preparation and Evaluation of [ Xiao D; Gan Q; Duan X; Wang Q; Jiang Y; Han P; Zhang J Mol Pharm; 2023 Sep; 20(9):4528-4536. PubMed ID: 37661815 [TBL] [Abstract][Full Text] [Related]
16. Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma. AbuHammad S; Cullinane C; Martin C; Bacolas Z; Ward T; Chen H; Slater A; Ardley K; Kirby L; Chan KT; Brajanovski N; Smith LK; Rao AD; Lelliott EJ; Kleinschmidt M; Vergara IA; Papenfuss AT; Lau P; Ghosh P; Haupt S; Haupt Y; Sanij E; Poortinga G; Pearson RB; Falk H; Curtis DJ; Stupple P; Devlin M; Street I; Davies MA; McArthur GA; Sheppard KE Proc Natl Acad Sci U S A; 2019 Sep; 116(36):17990-18000. PubMed ID: 31439820 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of a New Farahani AM; Maleki F; Sadeghzadeh N; Abediankenari S; Abedi SM; Erfani M Anticancer Agents Med Chem; 2020; 20(14):1695-1703. PubMed ID: 32560611 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and Bioevaluation of Novel Technetium-99m-Labeled Complexes with Norfloxacin HYNIC Derivatives for Bacterial Infection Imaging. Jiang Y; Fang S; Feng J; Ruan Q; Zhang J Mol Pharm; 2023 Jan; 20(1):630-640. PubMed ID: 36398935 [TBL] [Abstract][Full Text] [Related]
19. Combined Androgen receptor blockade overcomes the resistance of breast cancer cells to palbociclib. Ji W; Shi Y; Wang X; He W; Tang L; Tian S; Jiang H; Shu Y; Guan X Int J Biol Sci; 2019; 15(3):522-532. PubMed ID: 30745839 [TBL] [Abstract][Full Text] [Related]
20. Direct CDKN2 Modulation of CDK4 Alters Target Engagement of CDK4 Inhibitor Drugs. Green JL; Okerberg ES; Sejd J; Palafox M; Monserrat L; Alemayehu S; Wu J; Sykes M; Aban A; Serra V; Nomanbhoy T Mol Cancer Ther; 2019 Apr; 18(4):771-779. PubMed ID: 30837298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]